• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.
    All News #Library

    Harbin Jixianglong Biotech is on FDA Import Alert List

    FDA

    A. Nelson & Co.’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Aurobindo Pharma Limited, Unit VII

    FDA

    FDA Issues Form 483 to Eugia Pharma Specialities Limited

    FDA

    Sitashree Laxminarayn Best Chiwdais is on FDA Import Alert List

    FDA

    Cosmetic Manufacturers’s Receives FDA Warning Letter

    FDA

    Bertrand P Cole’s Receives FDA Warning Letter

    FDA

    Foshan Miwei Cosmetics is on FDA Import Alert List

    FDA

    Yangzhou H&R Plastic Daily Chemical is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to F.H. Investments Inc dba Asteria Health

    FDA

    ProDx Health’s Receives FDA Warning Letter

    FDA

    Central Coast Multispecialty’s Receives FDA Warning Letter

    FDA

    Mark S Dacey’s Receives FDA Warning Letter

    FDA

    Bio Medical Manufacturing’s Receives FDA Warning Letter

    FDA

    Signature Formulations’ Receives FDA Warning Letter

    FDA

    Boothwyn Pharmacy’s Receives FDA Warning Letter

    FDA

    Conceive Fertility Center’s Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of February 4, 2026

    FDA

    Panacea Biotec Limited Fails EDQM Inspection

    EMA

    HTO Nevada’s Receives FDA Warning Letter

    FDA

    Cohance Lifesciences’ Receives FDA Warning Letter

    FDA

    FD A Issues Form 483 toUS Specialty Formulations

    FDA

    Hangzhou Yiqi Biotechnology is on FDA Import Alert List

    FDA

    Hebei Shengxue Dacheng Pharmaceutical Fails EDQM Inspection

    EMA

    FDA Issues Form 483 to JKR Pharmacy Ventures

    FDA

    FDA Issues Form 483 to InnoStar Bio-Tech Nantong

    FDA

    Enforcement Report - Week of January 28, 2026

    FDA

    FDA Issues Form 483 to Empower Clinic Services dba Empower Pharma

    FDA

    Fulijaya Manufacturing SDN BHD’s Receives FDA Warning Letter

    FDA

    Center For Immunology’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Denver Solutions

    FDA

    Flowchem Pharma is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Joinn Laboratories Co.

    FDA

    FDA Issues Form 483 to Nubratori

    FDA

    FDA Issues Form 483 to Pine Pharmaceuticals

    FDA

    FDA Issues Form 483 to Petscript

    FDA

    FDA Issues Form 483 to Asahi Kasei Finechem Co.

    FDA

    Enforcement Report - Week of January 21, 2026

    FDA

    FDA Issues Form 483 to Sato Pharmaceutical Co.

    FDA

    FDA Issues Form 483 to Lupin Limited

    FDA

    Germaphobix’s Receives FDA Warning Letter

    FDA

    Genetrace’s Receives FDA Warning Letter

    FDA

    ProDx Health’s Receives FDA Warning Letter

    FDA

    Genovate’s Receives FDA Warning Letter

    FDA

    Integrity Partners Group’s Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of January 14, 2026

    FDA

    Finecure Pharmaceuticals Fails EDQM Inspection

    EMA

    Purushothaman Damodara Kumaran’s Receives FDA Warning Letter

    FDA

    Chemspec Chemicals’ Receives FDA Warning Letter

    FDA

    Winder’s Receives FDA Warning Letter

    FDA

    Anthony Trinh Issues Nationwide Recall of Silintan Capsules

    FDA

    Modern Recalls “Modern Warrior Ready” Dietary Supplement

    FDA

    Asanuma Corporation is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Pure Indulgence Aesthetics

    FDA

    Antaria Pty. Ltd. is on FDA Import Alert List

    FDA

    Cosmetic Manufacturers (Aust) Pty. is on FDA Import Alert List

    FDA

    Veganic SKN Limited is on FDA Import Alert List

    FDA

    PLZ Corp. is on FDA Import Alert List

    FDA

    Enforcement Report - Week of January 7, 2026

    FDA

    Tower’s Receives FDA Warning Letter

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.